

Cover Story
Conversation with The Cancer Letter
When Naoto T. Ueno left MD Anderson to become director of the University of Hawaiʻi Cancer Center, he took one of the most challenging jobs in oncology.
In Brief
Funding Opportunities
Clinical Roundup


Drugs & Targets


Trending Stories
- Class action complaint alleging GRAIL insider fraud resubmitted after dismissal
- How George Tidmarsh crossed the FDA-industry Rubicon
- Cancer centers adapt to life without site visits as NIH changes CCSG review
- Revolution Medicines’ pancreatic cancer drug received a new priority voucher from FDA
- How GLP-1RA drugs are reshaping patient physiology and the future of oncology
- CDER Director Tidmarsh quits amid inspector general probe of his “personal conduct”
Cancer advocates express concern about comments that signal trouble for accelerated approval
















